AstraZeneca PLC Strategic Asset Allocation Index
AstraZeneca PLC strategic asset allocation index. AstraZeneca PLC (AZN) has a Strategic Asset Allocation Index of 26.1% as of September 2023. Strategic assets (PP&E of GBX9.70 Billion plus long-term investments of GBX-) total GBX9.70 Billion, measured against net assets of GBX37.22 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See AZN equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of AstraZeneca PLC (2000–2022)
Strategic asset allocation index of AstraZeneca PLC from 2000 to 2022. This chart shows how AstraZeneca PLC's Strategic Asset Allocation Index has evolved across 23 annual periods from 2000 to 2022. As of September 2023, the index stands at 26.1%, representing strategic assets of GBX9.70 Billion against net assets of GBX37.22 Billion GBX. Check AstraZeneca PLC (AZN) tangible equity ratio to evaluate the tangible quality of the company's equity base.
AstraZeneca PLC Strategic Asset Allocation Index by Year (2000–2022)
AstraZeneca PLC strategic asset allocation index by year from 2000 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for AstraZeneca PLC from 2000 to 2022, covering 23 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see AstraZeneca PLC market capitalisation.
| Year | SAAI | Strategic Assets (GBX) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 25.5% | GBX9.45 Billion | GBX9.45 Billion | GBX- | GBX37.06 Billion | ▼ -0.4 pp |
| 2021 | 25.9% | GBX10.17 Billion | GBX10.17 Billion | GBX- | GBX39.29 Billion | ▼ -31.1 pp |
| 2020 | 57.0% | GBX8.92 Billion | GBX8.92 Billion | GBX- | GBX15.64 Billion | ▼ -10.4 pp |
| 2019 | 67.5% | GBX9.85 Billion | GBX8.34 Billion | GBX1.51 Billion | GBX14.60 Billion | ▲ +7.7 pp |
| 2018 | 59.8% | GBX8.40 Billion | GBX7.42 Billion | GBX978.00 Million | GBX14.04 Billion | ▲ +7.3 pp |
| 2017 | 52.5% | GBX8.73 Billion | GBX7.62 Billion | GBX1.12 Billion | GBX16.64 Billion | ▲ +6.1 pp |
| 2016 | 46.4% | GBX7.74 Billion | GBX6.85 Billion | GBX891.00 Million | GBX16.67 Billion | ▲ +8.0 pp |
| 2015 | 38.4% | GBX7.08 Billion | GBX6.41 Billion | GBX669.00 Million | GBX18.44 Billion | ▲ +4.1 pp |
| 2014 | 34.3% | GBX6.73 Billion | GBX6.01 Billion | GBX722.00 Million | GBX19.65 Billion | ▲ +9.2 pp |
| 2013 | 25.0% | GBX5.82 Billion | GBX5.82 Billion | GBX- | GBX23.25 Billion | ▼ -0.4 pp |
| 2012 | 25.4% | GBX6.09 Billion | GBX6.09 Billion | GBX- | GBX23.95 Billion | ▼ -2.0 pp |
| 2011 | 27.4% | GBX6.42 Billion | GBX6.42 Billion | GBX- | GBX23.47 Billion | ▼ -2.3 pp |
| 2010 | 29.7% | GBX6.96 Billion | GBX6.96 Billion | GBX- | GBX23.41 Billion | ▼ -5.4 pp |
| 2009 | 35.1% | GBX7.31 Billion | GBX7.31 Billion | GBX- | GBX20.82 Billion | ▼ -8.8 pp |
| 2008 | 43.9% | GBX7.04 Billion | GBX7.04 Billion | GBX- | GBX16.06 Billion | ▼ -11.8 pp |
| 2007 | 55.6% | GBX8.30 Billion | GBX8.30 Billion | GBX- | GBX14.91 Billion | ▲ +7.3 pp |
| 2006 | 48.3% | GBX7.45 Billion | GBX7.45 Billion | GBX- | GBX15.42 Billion | ▼ -2.7 pp |
| 2005 | 51.0% | GBX6.99 Billion | GBX6.99 Billion | GBX- | GBX13.69 Billion | ▼ -4.7 pp |
| 2004 | 55.8% | GBX8.08 Billion | GBX8.08 Billion | GBX- | GBX14.50 Billion | ▼ -1.1 pp |
| 2003 | 56.8% | GBX7.54 Billion | GBX7.54 Billion | GBX- | GBX13.26 Billion | ▼ -1.9 pp |
| 2002 | 58.8% | GBX6.60 Billion | GBX6.60 Billion | GBX- | GBX11.22 Billion | ▲ +2.6 pp |
| 2001 | 56.2% | GBX5.41 Billion | GBX5.41 Billion | GBX- | GBX9.63 Billion | ▲ +4.3 pp |
| 2000 | 51.9% | GBX4.96 Billion | GBX4.96 Billion | GBX- | GBX9.55 Billion | — |